New RX for pilots on pills
The US government has lifted a 70-year-old ban on letting pilots fly while on antidepressants, citing improvements in the drugs and an unforeseen side effect of the restriction: depressed pilots kept flying but just kept their conditions secret.
"Our concern is that they haven’t necessarily been candid," said Federal Aviation Administrator (FAA) Randy Babbitt.
The change in policy is aimed in part at clueing the government in on how many pilots suffer from a disease whose symptoms can include thoughts of suicide, FAA officials said.
How common is the condition among pilots?
About the same percentage as there is among the public, which is up to 10 percent, according to a study last year by Columbia University.
Under the ban, airline and other pilots who suspected they were depressed but wanted or financially needed to fly generally faced a choice: seek no medication for treatment, because doing so would disqualify them, or self-medicate and lie about it on a required medical certification form — a federal crime. Neither, Babbitt said, is acceptable.
"We need to change the culture and remove the stigma associated with depression," Babbitt said.
Under the new policy, pilots who take one of four antidepressants — Prozac, Zoloft, Celexa or Lexapro — or their generic equivalents will be allowed to fly if they have been successfully treated by those medications for a year without side effects that could pose a safety hazard in the cockpit.
The ban had endured because earlier generations of antidepressants caused concerns about side effects, such as drowsiness and seizures, Babbitt said. But a panel of medical experts for the FAA found during two years of research that newer versions don’t cause side effects in everyone. When they do occur, they tend to subside in time.
In addition, the FAA will grant a formof amnesty for pilots who have kept their treatment a secret. The agency will not take civil enforcement action against pilots who, within six months, disclose their diagnoses of depression and treatment.
By David Wilkening
David
Vegas’s Billion-Dollar Secrets – What They Don’t Want Tourists to Know
Visit Florida’s New CEO Bryan Griffin Shares His Vision for State Tourism with Graham
Chicago’s Tourism Renaissance: Graham Interviews Kristin Reynolds of Choose Chicago
Graham Talks with Cassandra McCauley of MMGY NextFactor About the Latest Industry Research
Destination International’s Andreas Weissenborn: Research, Advocacy, and Destination Impact
Graham and Don Welsh Discuss the Success of Destinations International’s Annual Conference
Graham and CEO Andre Kiwitz on Ventura Travel’s UK Move and Recruitment for the Role
Brett Laiken and Graham Discuss Florida’s Tourism Momentum and Global Appeal
Graham and Elliot Ferguson on Positioning DC as a Cultural and Inclusive Global Destination
Graham Talks to Fraser Last About His England-to-Ireland Trek for Mental Health Awareness
Kathy Nelson Tells Graham About the Honour of Hosting the World Cup and Kansas City’s Future
Graham McKenzie on Sir Richie Richardson’s Dual Passion for Golf and His Homeland, Antigua
ADS PRO 
France prepares for a massive strike across all transports on September 18
Turkish tourism stalls due to soaring prices for accommodation and food
CCS Insight: eSIMs ready to take the travel world by storm
Germany new European Entry/Exit System limited to a single airport on October 12, 2025
Airlines suspend Madagascar services following unrest and army revolt